Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.
Winter RJ, Stoové M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, McCarthy DR, Kinner SA
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M, Spelman T, Matthews GV, Haber PS, Day C, van Beek I, Walsh N, Yeung B, Bruneau J, Petoumenos K, Dolan K, Kaldor JM, Dore GJ, Hellard M, Grebely J, ATAHC Study Group
Agreement and mortality prediction in high-resolution CT of diffuse fibrotic lung disease.
Siemienowicz ML, Kruger SJ, Goh NS, Dobson JE, Spelman TD, Fabiny RP
An analysis of the thromboembolic outcomes of 2472 splenectomized individuals.
Dendle C, Spelman T, Sundararajan V, Chunilal S, Woolley I
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study.
Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M, InC3 study group
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J, International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study)